Drreddys Laboratories | RDY - Market Capitalization


Drreddys Laboratories reported INR1.98B in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
ANI Pharmaceuticals USD 1.88B 133M Jun/2026
Aurora Cannabis CAD 193.82M 133.39M Mar/2026
Bayer EUR 47.56B 8.87B Jun/2026
Canopy Growth CAD 557.13M 99.33M Mar/2026
Cipla INR 1.18T 194.93B Jun/2026
Corcept Therapeutics USD 9.33B 5.02B Jun/2026
Drreddys Laboratories INR 11.07B 619M Mar/2026
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
Hikma Pharmaceutical USD 4.63B 1.42B Dec/2025
Lonza CHF 39.68B 980.61M Jun/2025
Novartis USD 240.59B 67.17B Jun/2026
Pacira USD 998M 83M Jun/2026
Phibro Animal Health USD 1.51B 126M Dec/2025
Prestige Brands USD 2.24B 566M Jun/2026
Richter Gedeon HUF 2.21T 322.43B Mar/2026
Sun Pharmaceuticals INR 4.47T 248.76B Jun/2026
Supernus Pharmaceuticals USD 2.7B 277M Jun/2026
Teva Pharmaceutical Industries USD 114.54B 80.27B Jun/2026